BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2522807)

  • 1. Quinolinic acid concentrations in striatal extracellular fluid reach potentially neurotoxic levels following systemic L-tryptophan loading.
    During MJ; Heyes MP; Freese A; Markey SP; Martin JB; Roth RH
    Brain Res; 1989 Jan; 476(2):384-7. PubMed ID: 2522807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroactive metabolites of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid. Effect of tryptophan loading.
    During MJ; Freese A; Heyes MP; Swartz KJ; Markey SP; Roth RH; Martin JB
    FEBS Lett; 1989 Apr; 247(2):438-44. PubMed ID: 2523822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of extracellular quinolinic acid in the striatum studied by microdialysis in unanesthetized rats.
    Speciale C; Ungerstedt U; Schwarcz R
    Neurosci Lett; 1989 Oct; 104(3):345-50. PubMed ID: 2530475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular levels of quinolinic acid are moderately increased in rat neostriatum following severe insulin-induced hypoglycaemia.
    Westerberg E; Magnusson K; Wieloch T; Ungerstedt U; Speciale C; Schwarcz R
    Acta Physiol Scand; 1990 Mar; 138(3):417-22. PubMed ID: 2139298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain and plasma quinolinic acid in profound insulin-induced hypoglycemia.
    Heyes MP; Papagapiou M; Leonard C; Markey SP; Auer RN
    J Neurochem; 1990 Mar; 54(3):1027-33. PubMed ID: 1689373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolic and kynurenine pathway metabolites of tryptophan in rat brain: effect of precursor availability on in vivo release.
    During MJ; Heyes MP; Freese A; Swartz KJ; Matson WR; Markey SP; Martin JB; Roth RH
    Adv Exp Med Biol; 1991; 294():535-9. PubMed ID: 1837690
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex.
    Heyes MP; Quearry BJ; Markey SP
    Brain Res; 1989 Jul; 491(1):173-9. PubMed ID: 2475209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dextromethorphan does not protect against quinolinic acid neurotoxicity in rat striatum.
    Engber TM; Chase TN
    Neurosci Lett; 1988 Dec; 95(1-3):269-74. PubMed ID: 2976130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds.
    Foster AC; Collins JF; Schwarcz R
    Neuropharmacology; 1983 Dec; 22(12A):1331-42. PubMed ID: 6229703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolinic acid is extruded from the brain by a probenecid-sensitive carrier system: a quantitative analysis.
    Morrison PF; Morishige GM; Beagles KE; Heyes MP
    J Neurochem; 1999 May; 72(5):2135-44. PubMed ID: 10217295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic lipopolysaccharide and pokeweed mitogen increase quinolinic acid content of mouse cerebral cortex.
    Heyes MP; Kim P; Markey SP
    J Neurochem; 1988 Dec; 51(6):1946-8. PubMed ID: 2972813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydroaminoacridine potentiates neurotoxicity of quinolinic acid in rat striatum.
    Zhu SG; McGeer EG; Singh EA; McGeer PL
    Neurosci Lett; 1988 Dec; 95(1-3):252-6. PubMed ID: 2976129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delayed increases in regional brain quinolinic acid follow transient ischemia in the gerbil.
    Heyes MP; Nowak TS
    J Cereb Blood Flow Metab; 1990 Sep; 10(5):660-7. PubMed ID: 1696582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficiency of exogenous quinolinic acid, a metabolite of tryptophan, as a niacin precursor in rats.
    Shibata K; Murata K
    Adv Exp Med Biol; 1991; 294():645-7. PubMed ID: 1837696
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantification of quinolinic acid in rat brain, whole blood, and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations.
    Heyes MP; Markey SP
    Anal Biochem; 1988 Oct; 174(1):349-59. PubMed ID: 2975477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal ganglia lesions in the rat: effects on quinolinic acid metabolism.
    Schwarcz R; Okuno E; White RJ
    Brain Res; 1989 Jun; 490(1):103-9. PubMed ID: 2527078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease in rat cerebral quinolinic acid concentration following chronic hydrocortisone treatment.
    Connick J; Lombardi G; Beni M; Moroni F
    Neurosci Lett; 1988 May; 88(2):216-20. PubMed ID: 2454438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic treatments with GM1 ganglioside reduce quinolinic acid-induced striatal lesions in the rat.
    Lombardi G; Zanoni R; Moroni F
    Eur J Pharmacol; 1989 Dec; 174(1):123-5. PubMed ID: 2612575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of MK-801, kynurenate, glycine, dextrorphan and 4-acetylpyridine on striatal toxicity of quinolinate.
    Zhu SG; McGeer EG; McGeer PL
    Brain Res; 1989 Mar; 481(2):356-60. PubMed ID: 2524238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS dementia may be linked to metabolite of tryptophan.
    Cotton P
    JAMA; 1990 Jul; 264(3):305-6. PubMed ID: 2141881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.